Dempsey Robert John
SEC insider (Form 3/4/5 filer). CIK 0002125298. CHIEF EXECUTIVE OFFICER at OKYO Pharma Ltd (OKYO). 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 22, 2026. Located in LONDON.
Companies Dempsey Robert John has filed insider reports for
- OKYO Pharma Ltd (OKYO): Director, Officer, CHIEF EXECUTIVE OFFICER
Dempsey Robert John
CIK: 0002125298
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OKYO
OKYO Pharma Ltd
DirectorOfficer